Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02655432

Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population

Évaluation de l'Utilisation d'un Photoscreener Comme méthode de dépistage Des problèmes Ophtalmologiques pédiatriques en Haïti

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Université de Montréal · Academic / Other
Sex
All
Age
3 Years – 6 Years
Healthy volunteers
Accepted

Summary

Screening of haitian children between the ages of 3 and 6 years old for amblyogenic risk factors with the use of the Spot photoscreener. The photoscreener results will be compared to the complete ophthalmologic evaluation. Primarily, this will allow evaluation of the performance of the spot photoscreener in the haitian children population. Secondarily, this study will gather epidemiological information on vision problems in the haitian children population.

Detailed description

Screening of haitian children between the ages of 3 and 6 years old for amblyogenic risk factors with the use of the Spot photoscreener before and after cycloplegia. The photoscreener results will be compared to the complete ophthalmologic evaluation. The ophthalmologic evaluation includes visual acuity, ocular alignment, slit lamp evaluation, cycloplegic refraction and dilated fundus evaluation. First of all, this will allow evaluation of the performance of the spot photoscreener in the haitian children population. Second of all, this study will gather epidemiological information on vision problems in the haitian children population.

Conditions

Interventions

TypeNameDescription
DEVICESpot photoscreenerScreening of vision problem through an automated device
PROCEDUREOphthalmologic evaluationScreening of vision problem through an ophthalmologic evaluation
PROCEDURECyclopleged refractionScreening of refractive problems through a cyclopleged optometric refraction

Timeline

Start date
2016-01-01
Primary completion
2016-06-01
Completion
2016-06-01
First posted
2016-01-14
Last updated
2016-12-02

Locations

3 sites across 1 country: Haiti

Source: ClinicalTrials.gov record NCT02655432. Inclusion in this directory is not an endorsement.